Results 201 to 210 of about 2,301,317 (358)

Impact on the Safety of Blood Components due to the Elimination of Quarantine Storage for Fresh Plasma and the Implementation of a New Safety Standard. [PDF]

Transfus Med Hemother
Fiedler SA, Hoffelner M, Funk MB.
europepmc   +1 more source

Characteristics and outcomes of pediatric oncology patients at risk for guardians declining transfusion of blood components. [PDF]

Cancer Rep (Hoboken), 2023
Stevenson J, DeGroote NP, Keller F, Brock KE, Bergsagel DJ, Miller TP, Cornwell P, Fasano R, Chonat S, Castellino SM.   +9 more
europepmc   +1 more source

Effective prophylaxis against platelet refractoriness in multitransfused patients by use of leukocyte-free blood components [PDF]

, 1990
UM Saarinen, R. Kekomäki, MA Siimes, G. Myllylä   +3 more
openalex   +1 more source

LINC01116, a hypoxia‐lncRNA marker of pathological lymphangiogenesis and poor prognosis in lung adenocarcinoma

Molecular Oncology, EarlyView.
The LINC01116 long noncoding RNA is induced by hypoxia and associated with poor prognosis and high recurrence rates in two cohorts of lung adenocarcinoma patients. Here, we demonstrate that besides its expression in cancer cells, LINC01116 is markedly expressed in lymphatic endothelial cells of the tumor stroma in which it participates in hypoxia ...
Marine Gautier‐Isola, Rafael Lopes Goncalves, Marin Truchi, Caroline Lacoux, Célia Scribe, Hugo Cadis, Laetitia Guardini, Sophie Bekisz, Marius Ilié, Paul Hofman, Georges Vassaux, Bernard Mari, Roger Rezzonico   +12 more
wiley   +1 more source

Association of Anaesthetists guidelines: the use of blood components and their alternatives. [PDF]

Anaesthesia
Shah A, Klein AA, Agarwal S, Lindley A, Ahmed A, Dowling K, Jackson E, Das S, Raviraj D, Collis R, Sharrock A, Stanworth SJ, Moor P.   +12 more
europepmc   +1 more source

Effects of ZIF-8 MOFs on structure and function of blood components. [PDF]

RSC Adv, 2021
Lin J, Huang L, Ou H, Chen A, Xiang R, Liu Z.   +5 more
europepmc   +1 more source

Effects of bacterial cell wall components (PAMPs) on the expression of monocyte chemoattractant protein-1 (MCP-1), macrophage inflammatory protein-1α (MIP-1α) and the chemokine receptor CCR2 by purified human blood monocytes [PDF]

, 2003
Anne‐Sophie W. Møller, Reidun Øvstebø, Åse-Brit Westvik, Gun Britt Joø, Kari-Bente F. Haug, Peter Kierulf   +5 more
openalex   +1 more source

Developing evidence‐based, cost‐effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities

Molecular Oncology, EarlyView.
The cancer problem is increasing globally with projections up to the year 2050 showing unfavourable outcomes in terms of incidence and cancer‐related deaths. The main challenges are prevention, improved therapeutics resulting in increased cure rates and enhanced health‐related quality of life.
Ulrik Ringborg, Joachim von Braun, Julio Celis, Anton Berns, Michael Baumann, Tit Albreht, Nancy Abou‐Zeid, Vanderlei Bagnato, Christian Brandts, Chien‐Jen Chen, Massimiliano di Pietro, Manjit Dosanjh, Thomas Dubois, Alexander Eggermont, Angelika Eggert, Ingemar Ernberg, Sara Faithfull, Johannes Förner, Stefan Fröhling, Manuel Heitor, Leroy Hood, Wei Jiang, Bengt Jönsson, Ravi Kannan, Maria Leptin, Su Li, Peter Lindgren, Douglas Lowy, Jun Ma, Alex Markham, Péter Nagy, Simon Oberst, M. Iqbal Parker, Danielle Rodin, Kevin Ryan, Joachim Schüz, Richard Sullivan, Josep Tabernero, Peter Turkson, Oliver Várhelyi, Harold Varmus, Chijie Wang, Elisabete Weiderpass, Nils Wilking   +43 more
wiley   +1 more source

A Direct Comparison of the Performance of HemoCue Plasma/Low HB Analyzer versus Optical Spectroscopy for Quality Control Measurements of Free Hemoglobin in Blood Components. [PDF]

Transfus Med Hemother
Siller A, Seekircher L, Schmidt D, Tschiderer L, Willeit P, Schennach H, Amato M.   +6 more
europepmc   +1 more source

Blood components utilization in hematopoietic stem cell transplantation: Thirteen-year analysis from an apex oncology center of India. [PDF]

Asian J Transfus Sci, 2023
Ojha S, Patle V, Nagaraju P, Khattry N.
europepmc   +1 more source